| Title : Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia - Stryjer_2012_Clin.Neuropharmacol_35_161 |
| Author(s) : Stryjer R , Ophir D , Bar F , Spivak B , Weizman A , Strous RD |
| Ref : Clinical Neuropharmacology , 35 :161 , 2012 |
| Abstract : |
| PubMedSearch : Stryjer_2012_Clin.Neuropharmacol_35_161 |
| PubMedID: 22751086 |
| Title : Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia - Stryjer_2012_Clin.Neuropharmacol_35_161 |
| Author(s) : Stryjer R , Ophir D , Bar F , Spivak B , Weizman A , Strous RD |
| Ref : Clinical Neuropharmacology , 35 :161 , 2012 |
| Abstract : |
| PubMedSearch : Stryjer_2012_Clin.Neuropharmacol_35_161 |
| PubMedID: 22751086 |
| Title : Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia - Stryjer_2012_Clin.Neuropharmacol_35_161 |
| Author(s) : Stryjer R , Ophir D , Bar F , Spivak B , Weizman A , Strous RD |
| Ref : Clinical Neuropharmacology , 35 :161 , 2012 |
| Abstract : |
| PubMedSearch : Stryjer_2012_Clin.Neuropharmacol_35_161 |
| PubMedID: 22751086 |